Titre : Gyrus denté

Gyrus denté : Questions médicales fréquentes

Termes MeSH sélectionnés :

Atrophy
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Gyrus denté : Questions médicales les plus fréquentes", "headline": "Gyrus denté : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Gyrus denté : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-15", "dateModified": "2025-03-12", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Gyrus denté" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Hippocampe", "url": "https://questionsmedicales.fr/mesh/D006624", "about": { "@type": "MedicalCondition", "name": "Hippocampe", "code": { "@type": "MedicalCode", "code": "D006624", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.500.345" } } }, "about": { "@type": "MedicalCondition", "name": "Gyrus denté", "alternateName": "Dentate Gyrus", "code": { "@type": "MedicalCode", "code": "D018891", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "James J Knierim", "url": "https://questionsmedicales.fr/author/James%20J%20Knierim", "affiliation": { "@type": "Organization", "name": "Krieger Mind/Brain Institute, Johns Hopkins University, Baltimore, MD, USA." } }, { "@type": "Person", "name": "Hongjun Song", "url": "https://questionsmedicales.fr/author/Hongjun%20Song", "affiliation": { "@type": "Organization", "name": "Department of Neuroscience, University of Pennsylvania, Philadelphia, PA, 19104, USA; Mahoney Institute for Neurosciences, University of Pennsylvania, Philadelphia, PA, 19104, USA; Department of Developmental and Cell Biology, University of Pennsylvania, Philadelphia, PA, 19104, USA; Institute for Regenerative Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA; Institute for Epigenetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: shongjun@pennmedicine.upenn.edu." } }, { "@type": "Person", "name": "Steve Ramirez", "url": "https://questionsmedicales.fr/author/Steve%20Ramirez", "affiliation": { "@type": "Organization", "name": "Department of Psychological and Brain Sciences, Boston University, Boston, MA, USA." } }, { "@type": "Person", "name": "Kimberly M Christian", "url": "https://questionsmedicales.fr/author/Kimberly%20M%20Christian", "affiliation": { "@type": "Organization", "name": "Department of Neuroscience, University of Pennsylvania, Philadelphia, PA, 19104, USA; Mahoney Institute for Neurosciences, University of Pennsylvania, Philadelphia, PA, 19104, USA. Electronic address: kchristi@pennmedicine.upenn.edu." } }, { "@type": "Person", "name": "Guo-Li Ming", "url": "https://questionsmedicales.fr/author/Guo-Li%20Ming", "affiliation": { "@type": "Organization", "name": "Department of Neuroscience, University of Pennsylvania, Philadelphia, PA, 19104, USA; Mahoney Institute for Neurosciences, University of Pennsylvania, Philadelphia, PA, 19104, USA; Department of Developmental and Cell Biology, University of Pennsylvania, Philadelphia, PA, 19104, USA; Institute for Regenerative Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA; Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, 19104, USA; Institute for Epigenetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Pathology-specific patterns of cerebellar atrophy in neurodegenerative disorders.", "datePublished": "2023-12-18", "url": "https://questionsmedicales.fr/article/38109286", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/alz.13551" } }, { "@type": "ScholarlyArticle", "name": "Satisfaction and medication adherence in women with vulvovaginal atrophy: the CRETA.", "datePublished": "2023-04-05", "url": "https://questionsmedicales.fr/article/37017707", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/13697137.2023.2190508" } }, { "@type": "ScholarlyArticle", "name": "Genetic and clinical landscape of childhood cerebellar hypoplasia and atrophy.", "datePublished": "2022-10-28", "url": "https://questionsmedicales.fr/article/36305856", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.gim.2022.08.007" } }, { "@type": "ScholarlyArticle", "name": "Treatments for Age-related Vocal Atrophy: A Systematic Review.", "datePublished": "2023-03-13", "url": "https://questionsmedicales.fr/article/36912397", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/lary.30653" } }, { "@type": "ScholarlyArticle", "name": "Sex differences in brain atrophy in dementia with Lewy bodies.", "datePublished": "2023-12-22", "url": "https://questionsmedicales.fr/article/38131463", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/alz.13571" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Système nerveux", "item": "https://questionsmedicales.fr/mesh/D009420" }, { "@type": "ListItem", "position": 3, "name": "Système nerveux central", "item": "https://questionsmedicales.fr/mesh/D002490" }, { "@type": "ListItem", "position": 4, "name": "Encéphale", "item": "https://questionsmedicales.fr/mesh/D001921" }, { "@type": "ListItem", "position": 5, "name": "Prosencéphale", "item": "https://questionsmedicales.fr/mesh/D016548" }, { "@type": "ListItem", "position": 6, "name": "Télencéphale", "item": "https://questionsmedicales.fr/mesh/D013687" }, { "@type": "ListItem", "position": 7, "name": "Cerveau", "item": "https://questionsmedicales.fr/mesh/D054022" }, { "@type": "ListItem", "position": 8, "name": "Cortex cérébral", "item": "https://questionsmedicales.fr/mesh/D002540" }, { "@type": "ListItem", "position": 9, "name": "Hippocampe", "item": "https://questionsmedicales.fr/mesh/D006624" }, { "@type": "ListItem", "position": 10, "name": "Gyrus denté", "item": "https://questionsmedicales.fr/mesh/D018891" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Gyrus denté - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Gyrus denté", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Gyrus denté", "description": "Comment diagnostiquer une dysfonction du gyrus denté ?\nQuels tests neuropsychologiques sont utilisés ?\nLe gyrus denté peut-il être évalué par EEG ?\nQuels signes cliniques indiquent une atteinte du gyrus denté ?\nPeut-on utiliser des biomarqueurs pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D018891?mesh_terms=Atrophy&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Gyrus denté", "description": "Quels sont les symptômes d'une dysfonction du gyrus denté ?\nLa dépression est-elle liée au gyrus denté ?\nLes troubles de l'humeur affectent-ils le gyrus denté ?\nPeut-on observer des changements cognitifs ?\nLes troubles de l'anxiété impactent-ils le gyrus denté ?", "url": "https://questionsmedicales.fr/mesh/D018891?mesh_terms=Atrophy&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Gyrus denté", "description": "Comment prévenir les troubles du gyrus denté ?\nLe stress peut-il être prévenu ?\nL'éducation cognitive aide-t-elle à la prévention ?\nLes activités sociales sont-elles bénéfiques ?\nLe sommeil joue-t-il un rôle dans la prévention ?", "url": "https://questionsmedicales.fr/mesh/D018891?mesh_terms=Atrophy&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Gyrus denté", "description": "Quels traitements sont disponibles pour les troubles du gyrus denté ?\nLa thérapie comportementale est-elle efficace ?\nLes antidépresseurs peuvent-ils aider ?\nY a-t-il des approches non médicamenteuses ?\nLa stimulation cérébrale est-elle une option ?", "url": "https://questionsmedicales.fr/mesh/D018891?mesh_terms=Atrophy&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Gyrus denté", "description": "Quelles complications peuvent survenir avec une dysfonction du gyrus denté ?\nLes troubles de la mémoire peuvent-ils s'aggraver ?\nY a-t-il un risque accru de démence ?\nLes troubles de l'humeur peuvent-ils s'aggraver ?\nDes problèmes de comportement peuvent-ils survenir ?", "url": "https://questionsmedicales.fr/mesh/D018891?mesh_terms=Atrophy&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Gyrus denté", "description": "Quels sont les facteurs de risque pour les troubles du gyrus denté ?\nL'âge est-il un facteur de risque ?\nLes traumatismes crâniens augmentent-ils le risque ?\nLa consommation d'alcool est-elle un facteur de risque ?\nLe manque d'exercice physique est-il un risque ?", "url": "https://questionsmedicales.fr/mesh/D018891?mesh_terms=Atrophy&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction du gyrus denté ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests d'imagerie cérébrale comme l'IRM peuvent aider à évaluer la structure." } }, { "@type": "Question", "name": "Quels tests neuropsychologiques sont utilisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des évaluations de la mémoire et des fonctions cognitives sont couramment utilisées." } }, { "@type": "Question", "name": "Le gyrus denté peut-il être évalué par EEG ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "L'EEG peut montrer des anomalies d'activité cérébrale, mais pas spécifiquement du gyrus denté." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une atteinte du gyrus denté ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles de la mémoire et des difficultés d'apprentissage peuvent être des signes." } }, { "@type": "Question", "name": "Peut-on utiliser des biomarqueurs pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des recherches sont en cours sur les biomarqueurs, mais ils ne sont pas encore standardisés." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une dysfonction du gyrus denté ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des pertes de mémoire, des difficultés d'apprentissage et de l'anxiété." } }, { "@type": "Question", "name": "La dépression est-elle liée au gyrus denté ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des études montrent une association entre la dépression et des anomalies dans cette région." } }, { "@type": "Question", "name": "Les troubles de l'humeur affectent-ils le gyrus denté ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les troubles de l'humeur peuvent influencer la neurogenèse dans le gyrus denté." } }, { "@type": "Question", "name": "Peut-on observer des changements cognitifs ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des changements dans la cognition, comme des difficultés de concentration, peuvent survenir." } }, { "@type": "Question", "name": "Les troubles de l'anxiété impactent-ils le gyrus denté ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles anxieux peuvent affecter la fonction du gyrus denté et la mémoire." } }, { "@type": "Question", "name": "Comment prévenir les troubles du gyrus denté ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir un mode de vie sain, avec une alimentation équilibrée et de l'exercice, aide." } }, { "@type": "Question", "name": "Le stress peut-il être prévenu ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des techniques de gestion du stress comme la méditation peuvent aider à le réduire." } }, { "@type": "Question", "name": "L'éducation cognitive aide-t-elle à la prévention ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'éducation cognitive peut renforcer les capacités de mémoire et d'apprentissage." } }, { "@type": "Question", "name": "Les activités sociales sont-elles bénéfiques ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'engagement social peut améliorer la santé cognitive et prévenir les troubles." } }, { "@type": "Question", "name": "Le sommeil joue-t-il un rôle dans la prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un sommeil de qualité est crucial pour la santé du gyrus denté et la mémoire." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les troubles du gyrus denté ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la thérapie cognitive, les médicaments et la stimulation cérébrale." } }, { "@type": "Question", "name": "La thérapie comportementale est-elle efficace ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la thérapie comportementale peut aider à améliorer les symptômes liés au gyrus denté." } }, { "@type": "Question", "name": "Les antidépresseurs peuvent-ils aider ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains antidépresseurs peuvent favoriser la neurogenèse dans le gyrus denté." } }, { "@type": "Question", "name": "Y a-t-il des approches non médicamenteuses ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des techniques comme la méditation et l'exercice physique peuvent être bénéfiques." } }, { "@type": "Question", "name": "La stimulation cérébrale est-elle une option ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la stimulation cérébrale profonde est explorée pour traiter les dysfonctionnements." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une dysfonction du gyrus denté ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des troubles cognitifs sévères et des problèmes émotionnels." } }, { "@type": "Question", "name": "Les troubles de la mémoire peuvent-ils s'aggraver ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, sans traitement, les troubles de la mémoire peuvent s'aggraver avec le temps." } }, { "@type": "Question", "name": "Y a-t-il un risque accru de démence ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des dysfonctionnements du gyrus denté peuvent augmenter le risque de démence." } }, { "@type": "Question", "name": "Les troubles de l'humeur peuvent-ils s'aggraver ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les troubles de l'humeur peuvent s'aggraver sans intervention appropriée." } }, { "@type": "Question", "name": "Des problèmes de comportement peuvent-ils survenir ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des dysfonctionnements peuvent entraîner des problèmes de comportement et d'interaction." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les troubles du gyrus denté ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent le stress chronique, l'anxiété et des antécédents familiaux." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement est un facteur de risque pour les dysfonctionnements du gyrus denté." } }, { "@type": "Question", "name": "Les traumatismes crâniens augmentent-ils le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traumatismes crâniens peuvent endommager le gyrus denté et affecter la mémoire." } }, { "@type": "Question", "name": "La consommation d'alcool est-elle un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une consommation excessive d'alcool peut nuire à la fonction du gyrus denté." } }, { "@type": "Question", "name": "Le manque d'exercice physique est-il un risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire peut augmenter le risque de dysfonctionnement cognitif." } } ] } ] }

Sources (3010 au total)

Pathology-specific patterns of cerebellar atrophy in neurodegenerative disorders.

Associations of cerebellar atrophy with specific neuropathologies in Alzheimer's disease and related dementias (ADRD) have not been systematically analyzed. This study examined cerebellar gray matter ... Cerebellar gray matter volume was examined using voxel-based morphometry in 309 autopsy-proven ADRD cases and 80 healthy controls. ADRD subtypes included AD, mixed Lewy body disease and AD (LBD-AD), a... Distinct patterns of cerebellar atrophy were observed in all ADRD subtypes. Significant cerebellar gray matter changes appeared in the early stages of most subtypes and the very early stages of AD, LB... Our findings establish pathology-specific profiles of cerebellar atrophy in ADRD and propose cerebellar neuroimaging as a non-invasive biomarker for differential diagnosis and disease monitoring.... Cerebellar atrophy was examined in 309 patients with autopsy-proven neurodegeneration. Distinct patterns of cerebellar atrophy are found in all pathological subtypes of Alzheimer's disease and related...

Satisfaction and medication adherence in women with vulvovaginal atrophy: the CRETA.

This study aimed to evaluate the self-reported satisfaction of Spanish postmenopausal women currently treated for vulvovaginal atrophy (VVA) symptoms.... The CRETA (CRoss sectional European sTudy on Adherence) is a multicenter cross-sectional study conducted in 29 public and private hospitals in Spain, which enrolled postmenopausal women receiving trea... Among 752 women who completed the survey, the satisfaction score was significantly higher for the group treated with ospemifene (mean 8.3 ± 1.4) compared with the local HT group (7.2 ± 1.7) and the va... Among postmenopausal women with VVA, treatment with ospemifene has the most positive perceptions and the highest overall satisfaction level and could be an optimal therapeutic approach, maximizing pat...

Genetic and clinical landscape of childhood cerebellar hypoplasia and atrophy.

Cerebellar hypoplasia and atrophy (CBHA) in children is an extremely heterogeneous group of disorders, but few comprehensive genetic studies have been reported. Comprehensive genetic analysis of CBHA ... Patients with CBHA in 176 families were genetically examined using exome sequencing. Patients with disease-causing variants were clinically evaluated.... Disease-causing variants were identified in 96 of the 176 families (54.5%). After excluding 6 families, 48 patients from 42 families were categorized as having syndromic associations with CBHA, wherea... A wide genetic and clinical diversity of CBHA was revealed through exome sequencing in this cohort, which highlights the importance of comprehensive genetic analyses. Furthermore, molecular-based trea...

Treatments for Age-related Vocal Atrophy: A Systematic Review.

Age-related vocal atrophy (ARVA) can dramatically affect voice, communication, and quality of life. The objectives of this systematic review were to (1) determine whether treatments for ARVA were supe... The literature was searched using strategies designed by a medical librarian (2/18/21, updated 3/9/22). Studies investigating treatments for bilateral vocal atrophy were included. Studies involving un... After applying the inclusion/exclusion criteria, 8 articles remained, including 4 randomized trials and 4 cohort studies, and a narrative synthesis was performed. Surgical and behavioral treatments fo... When comparing treatments for ARVA. Surgery and voice therapy were both superior to control groups based on specific outcome measures from different domains. Superiority of one treatment could not be ... N/A Laryngoscope, 133:2846-2855, 2023....

Sex differences in brain atrophy in dementia with Lewy bodies.

Sex influences neurodegeneration, but it has been poorly investigated in dementia with Lewy bodies (DLB). We investigated sex differences in brain atrophy in DLB using magnetic resonance imaging (MRI)... We included 436 patients from the European-DLB consortium and the Mayo Clinic. Sex differences and sex-by-age interactions were assessed through visual atrophy rating scales (n = 327; 73 ± 8 years, 62... We found a higher likelihood of frontal atrophy and smaller volumes in six cortical regions in males and thinner olfactory cortices in females. There were significant sex-by-age interactions in volume... We demonstrate that males have more widespread cortical atrophy at younger ages, but differences tend to disappear with increasing age, with males and females converging around the age of 75.... Male DLB patients had higher odds for frontal atrophy on radiological visual rating scales. Male DLB patients displayed a widespread pattern of cortical gray matter alterations on automated methods. S...

Vulvovaginal atrophy in the CRETA study: the healthcare professionals' perception.

The objective is to assess the perception of gynecologists regarding patients' adherence to vulvovaginal atrophy (VVA) treatments, to evaluate the gynecologists' opinions on what their patients think ... Spanish gynecologists who participated in the CRETA study were asked to fill out an online 41-item questionnaire to evaluate their views on VVA management.... From 29 centers across Spain, 44 gynecologists completed the survey. Their mean age was 47.2 years old, two-thirds of them were women, and the average professional experience was over 20 years. Accord... Spanish gynecologists are in general agreement with their patients regarding VVA treatment preferences and the main issues for adherence and effectiveness. However, there is an opportunity for doctor-...

New developments in the management of vulvovaginal atrophy: a comprehensive overview.

Proper recognition and individualized therapy of vulvovaginal atrophy (VVA) is paramount.... Assessment of VVA should be performed using several questionnaires in combination with wet mount microscopy to determine Vaginal Cell Maturation Index (VCMI) and infections. PubMed searches were carri... Proper treatment is not possible without a correct and full diagnosis, including microscopy of the vaginal fluid. Low dose vaginal estrogen treatment, especially with estriol, is very efficient and is...

Grey matter atrophy in patients with benign multiple sclerosis.

Brain atrophy appears during the progression of multiple sclerosis (MS) and is associated with the disability caused by the disease.... We investigated global and regional grey matter (GM) and white matter (WM) volumes, WM lesion load, and corpus callosum index (CCI), in benign relapsing-remitting MS (BRRMS, n = 35) with and without a... The total brain and cerebral WM volumes were larger in BRRMS than in ARRMS (p = .014, p = .017 respectively). In BRRMS, total brain volumes, regional GM volumes, and CCI were found similar whether or ... Thalamic volume is the most prominent measure to differentiate BRRMS and ARRMS. Validation of automated quantification of CCI provides an additional applicable MRI biomarker to detect brain atrophy in...

The correlation of atrophy, traction and neovascularization in myopic choroidal neovascularization according to a novel myopic maculopathy classification system (atrophy (A), traction (T), neovascularization (N): ATN).

To grade myopic choroidal neovascularization (CNV) patients according to the new myopic maculopathy classification (A: atrophy, T: traction, N: neovascularization-ATN) and analyze the correlation in b... Fifty-one eyes of 41 patients with the diagnosis of pathologic myopia and myopic CNV were included in this clinical practice study. Patients were graded according to the recently described ATN classif... Active myopic CNV was observed most frequently in the group with patchy chorioretinal atrophy. Grade of the atrophy and female gender were significantly associated with myopic CNV scar in the univaria... ATN classification is a practical and comprehensive system to grade myopic CNV. Atrophy is an independent predictor for myopic CNV scar and patchy chorioretinal atrophy requires a more careful examina...